INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
05/08/2026
Back to search
Official data from USPTO
BCAL DX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
BCAL DX
ST13
US500000079391313Class
5, 10, 44
Filing
79391313
Registration
7691432
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
05/09/2026
Classification
Registered
Trademark type
Word
Nice classes
5, 10, 44
Filing date
01/23/2024
Registration date
02/18/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/18/2025
Last transaction
05/09/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
AU
Examiner
OH, HYUN-JUNG
Law office
O20
Current location
Historical data usage
Holders and representatives
Holders
BCal Diagnostics Limited
Representatives
Nicholas D. Myers THE MYERS LAW GROUP
Technical classification
Nice Classes
Class 5Class 10Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Chemical preparations for testing blood for medical purposes; diagnostic preparations for clinicalmedical or veterinary laboratory use; diagnostic preparations for medical purposes; diagnostic products in the nature of medical diagnostic biomarkers for medical purposes; diagnostic substances for medical use; diagnostic testing materials in the nature of diagnostic test patch for application to the skin for determining allergies for medical use; diagnostic agents for pharmaceutical use; diagnostic reagents for medical purposes; preparations for medical diagnostic use; reagents for blood grouping for medical purposes; blood testing apparatus including test erythrocytes for blood diagnostic purposes; medical adhesive tapes; medical dressings; medical or veterinary chemical products in the nature of chemical reagents for diagnostic tests for medical use; medical or veterinary chemical products in the nature of chemical reagents for use in biological preparations for medical purposes; medical or veterinary chemical products in the nature of chemical reagents for use with biotechnology for medical purposes; medical or veterinary chemical preparations in the nature of chemical reagents for the vaccines and antibodies chemical products in the nature of chemical reagents and antibody reagents for the detection of antigens in cells and tissue for medical and veterinary purposes; medical or veterinary chemical preparations for therapeuticsanitary pharmaceutical purposes for modulating or modifying lipids to improve disease outcomes for conditions includingdyslipidemiahypolipidemiacardiovascular diseasekidney diseasediabetesfatty liver diseaseobesityvascular diseasepancreatitishypothyroidismstrokemetabolic diseasesblood cancersbreast cancerlung cancerpancreatic cancerovarian cancer and other solids cancers; medical plasters; medical preparations for the treatment of dyslipidemiahypolipidemiacardiovascular diseasekidney diseasediabetesfatty liver diseaseobesityvascular diseasepancreatitishypothyroidismstrokemetabolic diseasesblood cancersbreast cancerlung cancerpancreatic cancerovarian cancer and other solids cancers; medical wound dressings * ; none of the aforesaid goods being pharmaceutical in nature *
Class 10
Diagnostic apparatus for carrying out diagnostic tests for testing blood-lipidsDNARNAproteinmetaboliteserythrocyteswhite blood cells used in medical laboratories for medical purposes; diagnostic apparatus for diagnostic and medical purposes used in medical laboratories for testing blood-lipidsDNARNAproteinmetaboliteserythrocyteswhite blood cells; diagnostic apparatus for medical diagnostic purposes used in medical laboratories for testing blood-lipidsDNARNAproteinmetaboliteserythrocyteswhite blood cellsapparatus for blood analysis; blood testing apparatus for blood tests; apparatus for testing blood; medical apparatus for use in blood analysis; medical apparatus for the treatment of cancer; blood cell analyzing apparatus for medical use; blood component separation apparatus for medical use; blood sampling apparatus for medical use; blood testing apparatus; blood testing equipmenthematology analyzers for medical diagnostic uses; diagnostic apparatus for medical purposes used in medical laboratories for testing blood-lipidsDNARNAproteinmetaboliteserythrocyteswhite blood cellselectromagnetic medical diagnostic imaging apparatus for medical use; immunochemical medical diagnostic testing apparatus for use in detecting and measuring antibody levels immunoassay procedures; immunochemical medical diagnostic testing instruments for use in detecting and measuring antibody levels immunoassay procedure; electromedical diagnostic instrumentselectrical nerve and muscle stimulatorsultrasonic stimulatorsmagnet therapy stimulators and laser therapy stimulators; gamma instruments for measuring human cell attenuation for medical usegamma cameras for medical purposes; diagnostic apparatus for medical purposes used in medical laboratories for testing blood-lipidsDNARNAproteinmetaboliteserythrocyteswhite blood cellsmedical apparatus for diagnostic purposes used in medical laboratories for testing blood-lipidsDNARNAproteinmetaboliteserythrocyteswhite blood cells and medical diagnostic apparatus for use in testing blood in medical laboratories; medical apparatus for medical diagnostic testing of biological samples; medical diagnostic apparatus for testing blood-lipidsDNARNAproteinmetabolites erythrocyteswhite blood cellsmedical diagnostic instruments for the analysis of body fluids; medical diagnostic testing apparatus for testing blood-lipidsDNARNAproteinmetabolites erythrocyteswhite blood cellstesting apparatus for medical diagnostic purposesapparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testingcytology and cell-based testing; testing instruments for medical diagnostic purposesapparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testingcytology and cell-based testing; tools for medical diagnosticstube for collection of blood sampleshematology analyzersmetabolite analyzersnucleic acid analyzers for medical diagnostics uses
Class 44
Medical analysis of tissues for the medical treatment of persons; blood testing services being medical analysis services for diagnostic and treatment purposes by medical laboratories; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis services relating to the diagnosis and treatment of persons; medical analysis services relating to the treatment of patients; medical diagnostic testingmonitoring and reporting services; surgical diagnostic services relating to the treatment of patients for medical purposes; health screening services in the field of dyslipidemiahypolipidemiacardiovascular diseasekidney diseasediabetesfatty liver diseaseobesityvascular diseasepancreatitishypothyroidismstrokemetabolic diseasesblood cancersbreast cancerlung cancerpancreatic cancerovarian cancer and other solids cancers; medical screening; medical services; medical monitoring and reporting services of patients; remote monitoring of medical data for medical diagnosis and treatment
Publications
History of USPTO decisions and trademark events.
42 publications found
NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
09/30/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/27/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/08/2025
FIMP
FINAL DISPOSITION PROCESSED
09/08/2025
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
09/08/2025
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
09/08/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/08/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
08/29/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/13/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
08/13/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/19/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/18/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
02/18/2025
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
01/04/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/31/2024
PUBO
PUBLISHED FOR OPPOSITION
12/31/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/25/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/05/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/04/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/04/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
12/04/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/19/2024
GNFR
FINAL REFUSAL E-MAILED
10/19/2024
CNFR
FINAL REFUSAL WRITTEN
10/19/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/23/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/23/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/23/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/20/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/20/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/20/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/20/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/20/2024
RFNT
REFUSAL PROCESSED BY IB
08/31/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/10/2024
RFRR
REFUSAL PROCESSED BY MPU
08/10/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/30/2024
CNRT
NON-FINAL ACTION WRITTEN
07/29/2024
DOCK
ASSIGNED TO EXAMINER
07/22/2024
MAFR
APPLICATION FILING RECEIPT MAILED
04/24/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/20/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/14/2024
Continuous trademark protection
Get notified about every new filing that threatens BCAL DX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.